Trifluoroacetic acid → 2-{4-(2-(azetidin-1-yl)-6-({(2-(4-chlorophenyl)-1,3-thiazol-4-yl)methyl}sulfanyl)-3,5-dicyanopyridin-4-yl)phenoxy}ethyl L-alaninate trifluoroacetate

HRID 1621342Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1621342
C(OC([NH:8][C@H:9]([C:11]([O:13][CH2:14][CH2:15][O:16][C:17]1[CH:22]=[CH:21][C:20]([C:23]2[C:28]([C:29]#[N:30])=[C:27]([S:31][CH2:32][C:33]3[N:34]=[C:35]([C:38]4[CH:43]=[CH:42][C:41]([Cl:44])=[CH:40][CH:39]=4)[S:36][CH:37]=3)[N:26]=[C:25]([N:45]3[CH2:48][CH2:47][CH2:46]3)[C:24]=2[C:49]#[N:50])=[CH:19][CH:18]=1)=[O:12])[CH3:10])=O)(C)(C)C.[F:51][C:52]([F:57])([F:56])[C:53]([OH:55])=[O:54]>ClCCl>[F:51][C:52]([F:57])([F:56])[C:53]([OH:55])=[O:54].[NH2:8][C@H:9]([C:11]([O:13][CH2:14][CH2:15][O:16][C:17]1[CH:22]=[CH:21][C:20]([C:23]2[C:28]([C:29]#[N:30])=[C:27]([S:31][CH2:32][C:33]3[N:34]=[C:35]([C:38]4[CH:39]=[CH:40][C:41]([Cl:44])=[CH:42][CH:43]=4)[S:36][CH:37]=3)[N:26]=[C:25]([N:45]3[CH2:46][CH2:47][CH2:48]3)[C:24]=2[C:49]#[N:50])=[CH:19][CH:18]=1)=[O:12])[CH3:10]

Komponenten

4

Versuchsvorschrift

39 mg (0.053 mmol) of 2-{4-(2-(azetidin-1-yl)-6-({(2-(4-chlorophenyl)-1,3-thiazol-4-yl)methyl}sulfanyl)-3,5-dicyanopyridin-4-yl)phenoxy}ethyl N-(tert-butoxycarbonyl)-L-alaninate (Example 13A) were initially charged in 1.5 ml dichloromethane. 0.5 ml (6.49 mmol) of trifluoroacetic acid was added, and the reaction solution was then stirred at RT for 1.5 h. The reaction solution was concentrated by evaporation and the residue was purified by preparative HPLC (acetonitrile/water+0.1% TFA). This gave 40 mg (100% of theory) of the target compound.

Aufarbeitung

  1. concentrationThe reaction solution was concentrated by evaporation
  2. customthe residue was purified by preparative HPLC (acetonitrile/water+0.1% TFA)

Quellen und Nachweise

ORD-Eintrag
ord-c83b7adf95b443a2a0acf068c218e61b
Quelldatensatz
uspto-grants-2014_07
Patentnummer
US08772498B2

Notizen zur Reaktion

Wird geladen…